Company: CGC
Filing Date: 2025-05-30
Form Type: POS AM
Source: 0001104659-25-054925
Chunk: 56

Company: Canopy Growth Corp
Filing Date: 2025-05-30
Form: POS AM
Chunk 56
---
77 per Common Share, which was the last reported sale price of our Common Shares on the Nasdaq Global Select Market on May 28, 2025, for aggregate gross proceeds of $172,069,635. The Common Shares subject to the Equity Distribution Agreement are being sold from time to time at various prices. An increase of $1.00 per Common Share in the price at which the Common Shares are sold from the assumed offering price of $1.77 per Common Share shown in the table above, assuming all of our Common Shares in the aggregate amount of $172,069,635 during the term of this offering are sold at that price, would increase our adjusted net tangible book value per Common Share after this offering to $1.68 per Common Share and would dilute the net tangible book value per Common Share to new investors in this offering by $1.09 per Common Share, after deducting the Commission and estimated aggregate offering expenses payable by us and assuming no Common Shares sold in the Concurrent Canadian Offering. A decrease of $1.00 per Common Share in the price at which the Common Shares are sold from the assumed offering price of $1.77 per Common Share shown in the table above, assuming all of our Common Shares in the aggregate amount of $172,069,635 during the term of this offering are sold at that price, would decrease our adjusted net tangible book value per share after this offering to $1.01 per Common Share and would result in investors in this offering purchasing Common Shares at $0.24 less than the as adjusted net tangible book value per Common Share after giving effect to the offering, after deducting an assumed commission of 3.0% and estimated offering expenses payable by us and assuming no Common Shares sold in the Concurrent Canadian Offering. This information is supplied for illustrative purposes only and may differ based on the actual offering price and the actual number of Common Shares sold in the offering. The discussion and table above are based on 183,865,295 Common Shares outstanding as of March 31, 2025, and excludes the following, in each case as of March 31, 2025: • 26,261,474 of our Common Shares issuable upon conversion of the issued and outstanding Exchangeable Shares (and assumes that no additional Common Shares are converted into Exchangeable Shares during the term of this offering);

S-13

TABLE OF CONTENTS

•

up to 3,648,915 of our Common Shares issuable upon the exercise of stock options outstanding as